nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Agitation and Depression in Frail Nursing Home Elderly Patients With Dementia: Treatment Characteristics and Service Use
|
Bartels, Stephen J. |
|
2003 |
11 |
2 |
p. 231-238 8 p. |
artikel |
2 |
Apathy and Executive Dysfunction in Mild Cognitive Impairment and Alzheimer Disease
|
Ready, Rebecca E. |
|
2003 |
11 |
2 |
p. 222-228 7 p. |
artikel |
3 |
A Pilot Study of Vitamins to Lower Plasma Homocysteine Levels in Alzheimer Disease
|
Aisen, Paul S. |
|
2003 |
11 |
2 |
p. 246-249 4 p. |
artikel |
4 |
A Structured, Open Trial of Risperidone Therapy for Delusions of Theft in Alzheimer Disease
|
Shigenobu, Kazue |
|
2003 |
11 |
2 |
p. 256-257 2 p. |
artikel |
5 |
Donepezil HCl (E2020) Maintains Functional Brain Activity in Patients With Alzheimer Disease: Results of a 24-Week, Double-Blind, Placebo-Controlled Study
|
Tune, Larry |
|
2003 |
11 |
2 |
p. 169-177 9 p. |
artikel |
6 |
Drug Development and Alzheimer Disease
|
Roses, Allen D. |
|
2003 |
11 |
2 |
p. 123-130 8 p. |
artikel |
7 |
Effect of Light on Agitation in Institutionalized Patients With Severe Alzheimer Disease
|
Ancoli-Israel, Sonia |
|
2003 |
11 |
2 |
p. 194-203 10 p. |
artikel |
8 |
17β-Estradiol Reduces Plasma Aβ40 for HRT-Naïve Postmenopausal Women With Alzheimer Disease: A Preliminary Study
|
Baker, Laura D. |
|
2003 |
11 |
2 |
p. 239-244 6 p. |
artikel |
9 |
Executive Dysfunction and Apathy Predict Functional Impairment in Alzheimer Disease
|
Boyle, Patricia A. |
|
2003 |
11 |
2 |
p. 214-221 8 p. |
artikel |
10 |
Imaging-Based Measures of Disease Progression in Clinical Trials of Disease-Modifying Drugs for Alzheimer Disease
|
Matthews, Brandy |
|
2003 |
11 |
2 |
p. 146-159 14 p. |
artikel |
11 |
Impact of Study Design and Patient Population on Outcomes From Cholinesterase Inhibitor Trials
|
Anand, Ravi |
|
2003 |
11 |
2 |
p. 160-168 9 p. |
artikel |
12 |
Integrating Clinical and Ethical Dimensions of Capacity Assessments: A Response to Chopra et al.
|
Kim, Scott Y.H. |
|
2003 |
11 |
2 |
p. 258-259 2 p. |
artikel |
13 |
Interventions for Mild Cognitive Impairment and Alzheimer Disease: New Strategies, New Hope
|
Doraiswamy, P. Murali |
|
2003 |
11 |
2 |
p. 120-122 3 p. |
artikel |
14 |
Non-Steroidal Anti-Inflammatory Drug (NSAID) Use and Alzheimer Disease in Community-Dwelling Elderly Patients
|
Landi, Francesco |
|
2003 |
11 |
2 |
p. 179-185 7 p. |
artikel |
15 |
Sedative-Hypnotic Use of Diphenhydramine in a Rural, Older Adult, Community-Based Cohort: Effects on Cognition
|
Basu, Ranita |
|
2003 |
11 |
2 |
p. 205-213 9 p. |
artikel |
16 |
Semantic Interference in Mild Alzheimer Disease: Preliminary Findings
|
Loewenstein, David A. |
|
2003 |
11 |
2 |
p. 252-255 4 p. |
artikel |
17 |
The New and Improved Journal
|
Jeste, Dilip V. |
|
2003 |
11 |
2 |
p. 118-119 2 p. |
artikel |
18 |
Treatment-Related Decisional Capacity
|
Chopra, Mohit P. |
|
2003 |
11 |
2 |
p. 257-258 2 p. |
artikel |
19 |
Usefulness of Plasma Haloperidol Levels for Monitoring Clinical Efficacy and Side Effects in Alzheimer Patients With Psychosis and Behavioral Dyscontrol
|
Pelton, Gregory H. |
|
2003 |
11 |
2 |
p. 186-193 8 p. |
artikel |
20 |
Use of Cholinesterase Inhibitors in Clinical Practice: Evidence-Based Recommendations
|
Cummings, Jeffrey L. |
|
2003 |
11 |
2 |
p. 131-145 15 p. |
artikel |